Sunday, September 13, 2026 4:22 PM ET
2 days ago
A rapid-fire update on our 33-stock portfolio, including 6 stocks to buy now2 days ago
Rare disease is taking his vision. A gene therapy could help — if he can get it3 days ago
Jim Cramer says investors are too focused on AI stocks. Here's where he says to look instead4 days ago
'Patients pay the tariff': Swiss pharma CEO warns of Trump's generic drug tariff threat5 days ago
AstraZeneca's COPD drug shows late-stage trial wins, boosts blockbuster hopes5 days ago
Pharma major Novartis falls 10% after three drug trial setbacks5 days ago
Cholesterol drug setback casts doubt over multibillion-dollar race5 days ago
Billionaire family offices back healthcare and biotech startups in August10 days ago
Cramer: Here are 3 defensive stock market moves I'm making as oil and rates surge11 days ago
We're adding 2 stocks to our Bullpen watchlist because they meet these criteria11 days ago
This medical device stock looks like a gift for patient investors12 days ago
August was the month of the comeback kids. Cramer reviews what drove the biggest winners12 days ago
Trump strikes new drug pricing deals with nine midsized drugmakers13 days ago
BioCryst is profitable. Now it wants to buy more rare disease drugs16 days ago
How Taylor Farms became integral to America's food supply system16 days ago
FDA approves daily HIV pill from Gilead designed to simplify treatment16 days ago
HHS plans new FDA leadership roles for technology and drugs, sources say16 days ago
Why vaccination rates are falling in the U.S.19 days ago
BioMarin to acquire Alesta Therapeutics for $275 million23 days ago
Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar24 days ago
Hims & Hers CEO says FTC lawsuit misunderstands how the company works26 days ago
The startup using AI to help rare disease families develop custom treatments26 days ago
Court rules companies can't import Gilead medications from overseas26 days ago
Novo Nordisk CEO defends lawsuit against Eli Lilly: 'Competition has to be fair'1 month ago
Trump administration ends Medicaid, CHIP funding for gender-affirming care for children1 month ago
We're lifting our price target on Cardinal Health after issuing rosy profit guidance1 month ago
Trump wants to split the MMR vaccine. Experts say that's unlikely1 month ago
Jazz Pharmaceuticals to buy Actio Biosciences for $820 million1 month ago
Eli Lilly takes weight-loss pill battle global1 month ago
Trump signs order calling for fewer childhood vaccines, falsely linking shots to autism1 month ago
New genetic tests are catching rare diseases before symptoms start1 month ago